231 related articles for article (PubMed ID: 9454747)
21. Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH; Thiel E
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680
[TBL] [Abstract][Full Text] [Related]
22. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Dhaliwal HS; Rohatiner AZ; Gregory W; Richards MA; Johnson PW; Whelan JS; Gallagher CJ; Matthews J; Ganesan TS; Barnett MJ
Br J Cancer; 1993 Oct; 68(4):767-74. PubMed ID: 8398705
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.
Haioun C; Besson C; Lepage E; Thieblemont C; Simon D; Rose C; Tilly H; Sonet A; Lederlin P; Attal M; Brière J; Reyes F
Ann Oncol; 2000 Jun; 11(6):685-90. PubMed ID: 10942056
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
26. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
27. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.
Björkholm M; Hagberg H; Holte H; Kvaloy S; Teerenhovi L; Anderson H; Cavallin-Ståhl E; Myhre J; Pertovaara H; Ost A; Nilsson B; Osby E
Ann Oncol; 2007 Jun; 18(6):1085-9. PubMed ID: 17363838
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis.
Hollender A; Kvaloy S; Lote K; Nome O; Holte H
Eur J Cancer; 2000 Sep; 36(14):1762-8. PubMed ID: 10974623
[TBL] [Abstract][Full Text] [Related]
29. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
31. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
Hann IM; Eden OB; Barnes J; Pinkerton CR
Br J Haematol; 1990 Nov; 76(3):359-64. PubMed ID: 2261346
[TBL] [Abstract][Full Text] [Related]
32. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
Zinzani PL; Magagnoli M; Frezza G; Prologo G; Gherlinzoni F; Bendandi M; Albertini P; Babini L; D'Alessandro R; Tura S
Leuk Lymphoma; 1999 Feb; 32(5-6):571-6. PubMed ID: 10048430
[TBL] [Abstract][Full Text] [Related]
33. Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Zhang J; Chen B; Xu X
Leuk Lymphoma; 2014 Mar; 55(3):509-14. PubMed ID: 23741977
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.
Bromberg JE; Doorduijn JK; Illerhaus G; Jahnke K; Korfel A; Fischer L; Fritsch K; Kuittinen O; Issa S; van Montfort C; van den Bent MJ
Haematologica; 2013 May; 98(5):808-13. PubMed ID: 23144196
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
Chua SL; Seymour JF; Streater J; Wolf MM; Januszewicz EH; Prince HM
Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832
[TBL] [Abstract][Full Text] [Related]
36. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system involvement in patients with mantle cell lymphoma.
Oinonen R; Franssila K; Elonen E
Ann Hematol; 1999 Mar; 78(3):145-9. PubMed ID: 10211757
[TBL] [Abstract][Full Text] [Related]
38. Non Hodgkin's lymphoma involving the adrenal glands and the central nervous system (CNS): a particular evolution after chemotherapy.
Vélayoudom FL; Cardot-Bauters C; Decouvelaere AV; Vlaeminck V; Bauters F; Wémeau JL
Ann Endocrinol (Paris); 2005 Dec; 66(6):527-31. PubMed ID: 16357815
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
40. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]